41 results on '"Desterro, Joana"'
Search Results
2. Targeting mRNA processing as an anticancer strategy
3. OC 4 - NEXT GENERATION SEQUENCING APPROACH TO BONE MARROW FAILURE SYNDROMES – PORTUGUESE EXPERIENCE
4. Extramedullary T-lymphoblastic Crisis in a Myelodysplastic/Myeloproliferative Neoplasm with a t(12;22)/MN1::ETV6 Translocation
5. Screening a Targeted Panel of Genes by Next-Generation Sequencing Improves Risk Stratification in Real World Patients with Acute Myeloid Leukemia
6. Identification of putative biomarkers for leptomeningeal invasion in B-cell non-Hodgkin lymphoma by NMR metabolomics
7. Extramedullary T-lymphoblastic Crisis in a Myelodysplastic/Myeloproliferative Neoplasm with a t(12;22)/MN1::ETV6 Translocation.
8. An N-terminal p14ARF peptide blocks Mdm2-dependent ubiquitination in vitro and can activate p53 in vivo
9. SUMO‐1 modification activates the transcriptional response of p53
10. Acute Myeloid Leukemia with Isocitrate Dehydrogenases (IDH) 1 and 2 Mutations. a Real-World Study from the European IDH Research Group
11. UK Single Institution Experience of Mastocytosis: Guy's and St Thomas' NHS Foundation Trust
12. Targeting mRNA processing as an anticancer strategy
13. Essential thrombocythaemia treated with recombinant interferon: ‘real world' United Kingdom referral centre experience
14. P14ARF promotes accumulation of SUMO-1 conjugated (H)Mdm2
15. Polymeric Chains of SUMO-2 and SUMO-3 Are Conjugated to Protein Substrates by SAE1/SAE2 and Ubc9
16. Single Center Retrospective Study of Essential Thrombocythaemia Diagnosed Patients Treated with Interferon - Benefit and Tolerability
17. Identification of the Enzyme Required for Activation of the Small Ubiquitin-like Protein SUMO-1
18. CUANDO LA APLASIA ERITROIDE ES ALGO MÁS
19. In Vivo Requirement of the Small Subunit of U2AF for Recognition of a Weak 3′ Splice Site
20. Age-adjusted international prognostic index is a predictor of survival in gastric diffuse B-cell non-Hodgkin lymphoma patients
21. The NCCN-IPI Helps to Identify Very High-Risk Patients with DLBCL and Can be Improved By Other Independent Clinical Factors Including Bulky Disease and beta2-Microglobulin
22. Clinical Characteristics and Outcome of 104 Patients with Gastric Diffuse B-Cell Non-Hodgkin Lymphoma (DLBCL) a Multicenter Study
23. Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma
24. Author response: Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma
25. SETD2 is required for DNA double-strand break repair and activation of the p53-mediated checkpoint
26. Author response: SETD2 is required for DNA double-strand break repair and activation of the p53-mediated checkpoint
27. Common properties of the nuclear body protein SP100 and the TIF1alpha chromatin factor: the role of SUMO modification
28. Developing a prototype of an Oncobiology serious game for medical education
29. Splicing Factors SF1 and U2AF Associate in Extraspliceosomal Complexes
30. A Stochastic View of Spliceosome Assembly and Recycling in the Nucleus
31. SUMO-1 Modification Alters ADAR1 Editing Activity
32. A Stochastic View of Spliceosome Assembly and Recycling in the Nucleus
33. Intracellular Macromolecular Mobility Measured by Fluorescence Recovery after Photobleaching with Confocal Laser Scanning Microscopes
34. Dynamic association of RNA-editing enzymes with the nucleolus
35. Common Properties of Nuclear Body Protein SP100 and TIF1α Chromatin Factor: Role of SUMO Modification
36. Multiple C-Terminal Lysine Residues Target p53 for Ubiquitin-Proteasome-Mediated Degradation
37. SUMO-1 Modification of IκBα Inhibits NF-κB Activation
38. Ubch9 conjugates SUMO but not ubiquitin
39. An N-terminal p14ARF peptide blocks Mdm2-dependent ubiquitination in vitro and can activate p53 in vivo.
40. Intracellular macromolecular mobility measured by fluorescence recovery after photobleaching with confocal laser scanning microscopes.
41. Differential activation of basal and IL-7-induced PI3K/Akt/ mTOR and JAK/STAT5 signaling distinguishes pediatric from adult acute lymphoblastic leukemia.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.